Loading clinical trials...
Loading clinical trials...
A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-0976 or Fenofibrate in Subjects With Normal and Impaired Hepatic Function
Conditions
Interventions
Firsocostat
Fenofibrate
Locations
5
United States
Tustin, California, United States
Miami, Florida, United States
Orlando, Florida, United States
Minneapolis, Minnesota, United States
San Antonio, Texas, United States
Start Date
September 23, 2016
Primary Completion Date
May 5, 2019
Completion Date
May 13, 2019
Last Updated
December 17, 2020
NCT06318169
NCT05842512
NCT06216041
NCT04104321
NCT02443116
NCT04616014
Lead Sponsor
Gilead Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions